Table 2.
Factor | Expression Pattern Cells/Tissues | Known/Putative Function | Murine KO/Mutation Models | Phenotype: | |
---|---|---|---|---|---|
General | Teeth | ||||
| |||||
FGF23: Fibroblast growth factor 23 | Highest expression in bone and highly expressed during active bone remodeling. Noted in osteocytes, osteoblasts, cementoblasts, odontoblasts, and low levels in chondrocytes, cementocytes, and osteoclasts | Regulates Pi homeostasis by controlling renal reabsorption via modulation of expression of Pi co-transporters (i.e., NPT2a, NPT2c). Inhibits expression of α-hydroxylase required for formation of Vit D. DMP1 may modulate Fgf23 expression. Vit D regulates Fgf23 expression. | Fgf23 KO | General: Premature aging-like features, e.g., shortened lifespan, hypogonadism, emphysema, organ atrophy | Alveolar bone: Accumulation of unmineralized osteoid associated with ankylosis, apoptotic cells |
Lower levels in fetal vs. postnatal and adult tissues | Reports indicate that FGF23 signals through FGF type I receptors and requires Klotho binding for activation. Low FGF23 levels in fetal tissues, with high levels in young adult and adult tissues, suggests a role in mineral homeostasis vs. skeletal development. | Mineralized Tissues: Disorganized growth plate, accumulation of unmineralized osteoid, suppressed bone turnover, ectopic calcification, decreased mass & volume in long bones | Enamel: Defective in continually erupting rodent incisors, cyst-like appearance and lack of polarity to ameloblasts | ||
Altered circulating levels used to diagnose Pi-wasting diseases. | Pulp: Narrow chamber, ectopic matrix formation | ||||
Cementum: Normal appearance | |||||
PDL: Disorganized, and decreased width | |||||
Dentin: Normal appearance | |||||
| |||||
Klotho | Expressed predominantly in kidney, also in choroid plexus, parathyroid gland, and other tissues. | Single-pass transmembrane domain and short cytoplasmic domain having b-glucuronidase activity | Klotho KO | General: Similar to Fgf23 KO mouse, e.g., rapid aging syndrome including shortened lifespan, skin and muscle atrophy, osteoporosis, and emphysema. | Incisors: Ectopic calcification, altered odontoblast morphology (with defects in predentin and dentin) |
Soluble form in circulation | Extracellular domain: Shed and secreted in blood, considered a cofactor of FGF-23 signaling and suppressor of insulin/IGF-1 signaling. | Mineralized tissues: Accelerated osteoblast aging, ectopic calcification | Molars: Ankylosis with alveolar bone | ||
| |||||
PHEX: Phosphate regulating gene with homology to endopeptidases on the X chromosome | Highest expression in osteoblasts, osteocytes, and odontoblasts | Interacts with (cleaves) small circulating factors outside of the kidney to control renal Pi homeostasis and mineralization (e.g., MEPE, DMP-1, and other SIBLINGs), releasing acidic serine and aspartic acid-rich MEPE-associated motif (ASARM) peptides (“minhibins”), potent inhibitors of mineralization | Hyp mutant mouse (3’ deletion in Phex gene) | Growth retardation, osteomalacia, reduced mineralization in growth plate, reduced bone volume and osteoclasts in long bone | Alveolar bone: Hypomineralization, increased osteoid |
Regulates expression of Fgf-23 (may be indirect) | Dentin: Hypomineralization, interglobular dentin, widened predentin, irregular dentinal tubules | ||||
Pulp chamber: Enlarged | |||||
Enamel: Appears normal | |||||
Cementum: Disrupted globular appearance at SEM level (appears normal by H&E) | |||||
| |||||
DMP1: Dentin matrix protein 1 | High levels in osteocytes, also found in odontoblasts, cementoblasts/cytes | Considered to be required for mineralization; may regulate odontoblast and osteoblast/cyte specific genes; in osteocytes, considered to have a role in protection during mechanical loading; processed to NH2 and COOH fragments that are distributed differently in dentin and may have unique roles; suggested role as a transcription factor (regulates Dspp); may regulate Fgf-23 expression | Dmp1 KO | Increased osteoid, hypomineralized bone, defective osteocyte maturation, osteomalacia rickets, decreased bone mineral, increased crystal size | Dentin: Similar to Hyp mouse, e.g., hypomineralized with widened predentin |
PDL: Disorganized, with detachment from cementum |
No tooth phenotype reported for Mepe KO mouse; No animal models for loss of FRP4, FGF7.